• Sipai Health swung to an IFRS net profit of RMB 42.92 million, reversing an IFRS net loss a year earlier.
• Revenue fell 39.6% to RMB 739.92 million, hit by a 55.8% drop in specialty pharmacy to RMB 408.81 million.
• Gross margin widened 5.7 percentage points to 20.1% as the mix shifted toward higher-margin commercial insurance services.
• Corporate insurance services revenue climbed 37.7% to RMB 58.93 million; physician research assistance rose 16% to RMB 249.49 million.
• Acquisition of Jianyi Information Technology advanced; the deal had not completed, with a RMB 259.8 million transaction deposit posted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sipai Health Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12292902), on August 20, 2026, and is solely responsible for the information contained therein.